According to their studies, the bioactive LMs derived from n-6 PUFAs are abundant in psoriasis skin, while resolving D1 (RvD1), resolving D5 (RvD5), protectin D1 (PD1) and its double dioxygenation isomer 10S,17S-diHDHA (a.k.a. PDx), the aspirin-triggered forms of Lipoxin A4 and Lipoxin B4 (AT-LXA4 & AT-LXB4) may be the potent SPMs to resolve the inflammatory responses in the pathophysiology of psoriasis [147, 148]. Here, PDCD1 is linked to psoriasis.